Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Shares Outstanding (2023 - 2025)

Onconetix (ONCO) has disclosed Shares Outstanding for 2 consecutive years, with -$12934.0 as the latest value for Q3 2024.

  • On a quarterly basis, Shares Outstanding rose 97.5% to -$12934.0 in Q3 2024 year-over-year; TTM through Sep 2024 was -$12934.0, a 97.5% increase, with the full-year FY2023 number at -$12934.0, changed N/A from a year prior.
  • Shares Outstanding was -$12934.0 for Q3 2024 at Onconetix, down from $6704.0 in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $2.7 million in Q2 2024 to a low of -$517399.0 in Q2 2023.